Patents by Inventor Diane Petrone

Diane Petrone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunoglobulin cleavage fragments and disease indicators and compositions for detecting and binding such
    Patent number: 9481734
    Abstract: The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG protease cleavage products to restore effector function to antibody compositions that are subject to protease cleavage.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: November 1, 2016
    Assignee: Janssen Biotech, Inc.
    Inventors: Robert Jordan, David Knight, Randall Brezski, Mary Ryan, Diane Petrone
  • Immunoglobulin Cleavage Fragments and Disease Indicators and Compositions for Detecting and Binding Such
    Publication number: 20130239238
    Abstract: The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG protease cleavage products to restore effector function to antibody compositions that are subject to protease cleavage.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 12, 2013
    Applicant: JANSSEN BIOTECH INC.
    Inventors: Robert Jordan, David Knight, Randall Brezski, Mary Ryan, Diane Petrone
  • Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
    Patent number: 8501907
    Abstract: The invention relates to antibody compositions and use of the composition to detect disease processes associated with elaboration of proteases. The reagents are directed to assessing an IgG breakdown product that is the result of such proteolytic cleavage. The invention further relates to the use of a therapeutic immunospecific for IgG protease cleavage products to restore effector function to antibody compositions that are subject to protease cleavage.
    Type: Grant
    Filed: November 19, 2010
    Date of Patent: August 6, 2013
    Assignee: Janssen Biotech, Inc.
    Inventors: Robert Jordan, David Knight, Randall Brezski, Mary Ryan, Diane Petrone